Search

everythinglearnresearchcommunity

for

Search:↓

Lychnophora salicifolia extract in liposomes may protect skin from UV damage and inflammation.

The MPA-ISO cocrystal improved solubility and dissolution rate, while the others did not.

Certain antiparasitics and antidepressants show promise for treating cryptococcosis, especially when combined with fluconazole.

The method is effective and suitable for testing finasteride tablets.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Methotrexate-loaded formulations showed promise for psoriasis treatment but need careful evaluation.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

A new method accurately measures a drug in skin for cancer therapy research.

Chitrak is a medicinal plant with health benefits like fighting microbes, reducing inflammation, and promoting hair growth, but it can be toxic and needs more research.

Rosacea is a skin condition with unclear causes, classified into four subtypes.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

The guideline offers current advice for diagnosing and treating Long- and Post-COVID symptoms.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

Skin diseases differ between Ghana and the UK, with infections most common in Ghana and malignant skin diseases most prevalent in the UK.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

Skin has specialized touch receptors that can tell different sensations apart.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.